Aptamer Group
APTA · AIM · Health Care · mcap £11m · 0.3p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 07 Oct 26 | Routine | Notice of Results, Analyst & Investor Presentation | |
| 20 Aug 26 | Appointment of Joint Corporate Broker
Aptamer Group plc (AIM: APTA), the developer of next-generation synthetic Optimer® binders, is pleased to announce the appointment of Cavendish Capital Markets Limited ("Cavendish") as Joint Corporate Broker to the Compa |
+0.0% | |
| 14 Aug 26 | Director Fee Shares and Grant of Options
Aptamer Group plc (AIM: APTA), the developer of next-generation synthetic Optimer® binders, today announces that it has issued 12,936,511 new ordinary shares as payment for Non-Executive services and, in line with the Co |
−5.9% | |
| 13 Jul 26 | Trading update | Trading Update
Aptamer Group plc (AIM: APTA), the developer of next-generation synthetic Optimer® binders, today provides a trading update for the year ended 30 June 2026 ("FY2026"). |
+0.0% |
| 08 Jul 26 | Aptamer initiates Ebola diagnostic test programme
New programme to develop rapid diagnostic test for rare Bundibugyo Ebola strain during largest outbreak on record |
+0.0% | |
| 25 Jun 26 | Programme and technical development update
First AI-generated Optimer® candidates delivered for laboratory testing |
+4.8% | |
| 08 Jun 26 | Rapid testing programme for fortified foods
Aptamer initiates rapid testing programme for fortified foods |
+0.0% | |
| 13 Apr 26 | Routine | Result of General Meeting | |
| 31 Mar 26 | Fundraise | Result of Retail Offer and Posting of Notice of GM
£4.5 million raised pursuant to the Placing, Subscription and the Retail Offer |
+4.3% |
| 26 Mar 26 | Fundraise | Retail Offer to raise up to £0.5 million
Retail Offer to raise up to £0.5 million |
+0.0% |
| 26 Mar 26 | Results | Results of Placing
Aptamer Group plc (AIM: APTA), the leading developer of next-generation synthetic binders delivering innovation to the life science industry, announces that is has successfully raised gross proceeds of £4.275 million bef |
+0.0% |
| 25 Mar 26 | Results | Interim Results and Notice of Investor Webinar
Interim results for the six months ended 31 December 2025 |
−3.8% |
| 25 Mar 26 | Fundraise | Proposed Placing, Subscription and Retail Offer
Aptamer Group plc (AIM: APTA), the leading developer of next-generation synthetic binders delivering innovation to the life science industry, announces its intention to conduct an equity Fundraise to raise gross proceeds |
−3.8% |
| 18 Mar 26 | Launch of targeted radiopharmaceutical programme
Three therapeutic targets selected across high‑value clinical indications |
+0.0% | |
| 10 Mar 26 | Routine | Block Listing Interim Review | |
| 17 Feb 26 | Technical Feasibility for Pathogen Detector
Aptamer Group plc (AIM: APTA), the developer of next-generation synthetic binders for the life sciences industry, is pleased to announce the successful completion of Phase 1 of its collaboration with Metir plc ("Metir") |
+0.0% | |
| 11 Feb 26 | Optimer® Technology in Launched Library Prep Kit
Optimer® Technology in Newly Launched Library Prep Kit |
−2.6% | |
| 29 Jan 26 | Contract wins and first cash licensing receipts
Further repeat contract wins and first cash licensing receipts |
+2.9% | |
| 07 Jan 26 | Trading update | Trading update - Media comment and speculation
Aptamer Group plc (AIM: APTA), the developer of next-generation synthetic binders for the life sciences industry, provides an update regarding media comment and speculation following the trading update released by the Co |
+0.0% |
| 07 Jan 26 | Trading update | Half Year Trading Update
Revenue up 27% to £0.83 million with an FY26 fee-for-service order book of over £2.0 million |
+0.0% |
| 23 Dec 25 | Aptamer signs licensing agreement with Alphazyme
Royalty payments on product sales plus milestone and manufacturing revenues |
+11.2% | |
| 16 Dec 25 | Licensing agreement with Twist Bioscience
Non-exclusive license for Optimer® binder targeting the next-generation sequencing market |
+9.7% | |
| 27 Nov 25 | Result of AGM
Aptamer Group plc (AIM: APTA), the leading developer of next-generation synthetic binders delivering innovation to the life science industry, today announces that the results of voting on the resolutions put to sharehold |
+0.0% | |
| 27 Nov 25 | AGM Statement
Aptamer Group plc (AIM: APTA), the leading developer of next-generation synthetic binders delivering innovation to the life science industry, will hold its Annual General Meeting (AGM) at 11:00 am today at the offices of |
+0.0% | |
| 14 Nov 25 | Strong contract wins build commercial momentum
Strong contract wins continue to build commercial momentum |
+2.6% | |
| 04 Nov 25 | New contract with top five pharma company
Aptamer secures major repeat business with top 5 pharmaceutical partner |
+3.1% | |
| 03 Nov 25 | Routine | Posting of Annual Report and Notice of AGM | |
| 14 Oct 25 | Results | Final Results
Full year results for the twelve months ended 30 June 2025 |
−11.1% |
| 13 Oct 25 | New contract with top 10 pharma
£112,000 contract builds revenue visibility and reinforces Optimer® momentum |
−5.7% | |
| 10 Oct 25 | Routine | Notice of Results, Analyst & Investor Presentation | |
| 08 Oct 25 | Major top 3 global pharma contract win
£665,000 of additional contract value in recently signed agreements, £315,000 of smaller deals |
+15.8% |
Company filings. Not investment advice.